Abstract
Among the known non-benzodiazepinic hypnotic drugs acting on the alpha1 subunit of the GABA-A receptor, Zolpidem, Zaleplon and Indiplon have showed high affinity and selectivity. Following a design methodology including pharmacophoric requirements and ADME-predicted properties, we have synthesized a library of 3-amino-4,5-dihydro-1H-pyrazolo[3,4-b]pyridin-6(7H)-ones and their N1-alkyl derivatives as new scaffolds for designing non-benzodiazepine BZ receptor ligands.
MeSH terms
-
Animals
-
Benzodiazepines / chemistry
-
Benzodiazepines / pharmacology
-
Drug Design*
-
Hypnotics and Sedatives / chemical synthesis*
-
Hypnotics and Sedatives / chemistry
-
Hypnotics and Sedatives / pharmacology
-
Male
-
Pyrazoles / chemistry
-
Pyridines / chemistry
-
Pyridines / pharmacology
-
Pyridones / chemical synthesis*
-
Pyridones / chemistry
-
Pyridones / pharmacology
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, GABA-A / drug effects
-
Structure-Activity Relationship
-
Thiophenes / chemistry
-
Thiophenes / pharmacology
-
Zolpidem
Substances
-
Hypnotics and Sedatives
-
Pyrazoles
-
Pyridines
-
Pyridones
-
Receptors, GABA-A
-
Thiophenes
-
Benzodiazepines
-
Zolpidem
-
indiplon